|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/48 | |
| A61P 7/04 | |||
| A61K 35/14 |
| (11) | Patento numeris | 2364165 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09756209.4 |
| Europos patento paraiškos padavimo data | 2009-11-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-09-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/064060 |
| Data | 2009-11-11 |
| (87) | Numeris | WO 2010/056765 |
| Data | 2010-05-20 |
| (30) | Numeris | Data | Šalis |
| 114948 P | 2008-11-14 | US |
| (72) |
LU, Genmin, US
SINHA, Uma, US
|
| (73) |
Portola Pharmaceuticals, Inc.,
270 East Grand Avenue Suite 22, South San Francisco California 94080,
US
|
| (54) | ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME IN COMBINATION WITH BLOOD COAGULATING AGENTS |
| ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME IN COMBINATION WITH BLOOD COAGULATING AGENTS |